NRI

Themis Medicare Ltd

Sector Pharmaceuticals
BSE 530199
NSE THEMISMED
188.52
-12.77 (-6.34 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

184.81

Day High

203.47

52 Week Low

180.55

52 Week High

317.00

All Time Low

4.00

All Time High

317.00

Open

201.00

Close

201.29

Volume

153,341

Mkt cap (Cr)

1,735.14

P/E ratio

33.07

P/B ratio

0.22%

Div yield

0.26%

6M return

-19.76%

1Y return

-7.38%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

188.52 -6.34%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Themis Medicare Ltd

Stock PE (TTM)

33.07

Promoter Holding

67.15%

Book Value

41.139

ROCE

14.99%

ROE

13.39%

Themis Medicare Limited was formerly incorporated as `Themis Chemicals Limited` in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001. The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. In Mar.`95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital. Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis, cerebroactivators, bronchodilators, anti-asthmatic, anaesthetic and other segments. Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an anti-bacterial drug, for veterinary use for which it has a confirmed buy-back arrangement with Chinoin, Hungary. The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies. The Company introduced products like Cardiac and Muscular Relaxant during the year 2001-02. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 2002-03. M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, "Richter Themis Medicare (India) Pvt. Ltd." started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 2006-07. `Themiseal`, the Company`s unique haemostatic and anti-microbial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia. During the year 2010-11, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011. During FY 2016-17, HID-PUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. "Carpo Medical Limited" was incorporated as a Joint Venture Company in the United Kingdom in 2016-17. The Company launched a new product - Lenzetto Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms in 2023. As part of a strategy to concentrate on both the API and the Hospital Business, the Company demerged the API segment of the Company, including both the API production facilities, to a 100% owned subsidiary company, Themis Lifestyle Private Limited through slump sale in 2023.

Themis Medicare share price as on 17 Feb 2025 is Rs. 188.52. Over the past 6 months, the Themis Medicare share price has decreased by 19.76% and in the last one year, it has decreased by 7.38%. The 52-week low for Themis Medicare share price was Rs. 180.55 and 52-week high was Rs. 317.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

530199

THEMISMED

INE083B01024

Sep

Themis Medicare Ltd FAQs

You can buy Themis Medicare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Themis Medicare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 14, 2025 03:55 PM the closing price of Themis Medicare Ltd was Rs.188.52.

The latest PE ratio of Themis Medicare Ltd as of Feb 14, 2025 03:55 PM is 33.07

The latest PB ratio of Themis Medicare Ltd as of Feb 14, 2025 03:55 PM is 0.22

The 52-week high of Themis Medicare Ltd share price is Rs. 317.00 while the 52-week low is Rs. 180.55

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 14, 2025 03:55 PM, the market cap of Themis Medicare Ltd stood at Rs. 1,735.14 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.